Table 3 IC50 assessment of miyabeacin 3 in six cancer cell lines.
From: Miyabeacin: A new cyclodimer presents a potential role for willow in cancer therapy
Cancer Type | Cell Line | Miyabeacin IC50 (μg/mL) |
|---|---|---|
Breast | BT-474 | 27.04 |
Oesophageal | COLO-680N | 5.08 |
Ovarian | COLO-704 | 20.18 |
Ovarian | EFO-21 | 12.69 |
Breast | MCF-7 | 2.19 |
Neuroblastoma | UKF-NB-3 | 7.12 |
